Observational Study for SIR-Spheres Therapy for the Treatment of HCC Patients in China

NCT06712017 · clinicaltrials.gov ↗

ENROLLING_BY_INVITATION

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatocellular Carcinoma (HCC)
Hepatocellular Carcinoma Non-Resectable

Interventions

DEVICE: Yttrium-90 (Y-90) resin microspheres

Sponsor

GrandPharma (China) Co., Ltd.